Hints and tips:
Related Special Reports
...After the latter was bought by Swiss pharmaceutical group Roche in 2009, he rose through the ranks, becoming Genentech’s chief executive in 2017 and Roche’s head of pharma two years later....
...The Swiss group made SFr58.7bn ($68bn) in 2023, a 7 per cent decline from SFr63.2bn in 2022 and below analysts’ estimates....
...Barclays estimates the market could be worth $100bn within a decade, Switzerland’s Roche has just boosted its chances of being a contender....
...Roche is to acquire Carmot Therapeutics for up to $3.1bn, in the industry’s latest significant investment in the booming obesity treatment market....
...That holds true for pharmaceutical companies which are looking a bit peaky. Roche, whose stock has fallen 27 per cent in the past 12 months, is a case in point....
...Roche first tried to develop a drug using GLP-1s more than a decade ago, before ditching the attempt....
...House, San Miguel de Allende, $1.3mn Where In the historic centre of San Miguel de Allende, which has two international airports within 100km....
...Miguel Zenón’s impressive career takes in 14 years as lead alto saxophonist with the starry SFJazz Collective, 15 own-name albums and a long list of sideman credits....
...Roche will pay $7.1bn upfront and a near term milestone payment of $150mn. Roivant owns 75 per cent of Telavant, while Pfizer owns 25 per cent....
...As a veteran reader of the FT, I agree with Richard Styles (“A farmer makes the case for teaching Pythagoras”, Letters, December 30) about the usefulness of Pythagoras....
...Roche will pay $7.1bn upfront and a near-term milestone payment of $150mn. Pfizer will keep the commercialisation rights outside the US and Japan....
...On Monday morning, Cuban President Miguel Díaz-Canel blamed the current unrest on “mediocre politicians and social media terrorists organised from South Florida”, where many Cuban exiles live....
...Rocío San Miguel, a lawyer and military analyst, was detained on Friday by authorities at the Maiquetía airport near Caracas while waiting to board a flight to Miami with her adult son....
...The move comes after UN officials joined a chorus of international voices in criticising the arrest of Rocío San Miguel, a prominent human rights lawyer and military analyst, last Friday on terrorism charges...
...Roche is therefore acquiring US-based obesity drugs developer Carmot for up to $3.1bn. The Swiss company already has a packed pipeline. The problem is that too many drug trials have failed....
...Already this year Venezuela has arrested Rocío San Miguel, a prominent opposition military analyst and lawyer, while members of her family briefly also went missing....
...Roche has inadvertently disclosed positive results from a closely watched lung cancer drug study, sending shares in the Swiss pharma group up as much as 5 per cent....
...Sanofi trades on a forward price/earnings ratio of 11 times, Roche on 12.4 times and Novartis on 14.5 times. By comparison, obesity drugs developer Novo Nordisk trades on 33.6 times....
...The director Miguel Garay (Manolo Solo) is now grey and eyebagged. His star, also his best friend, disappeared after shooting the scene we opened with. Rumours abound....
...The crunchy acronym was coined by Goldman Sachs for pharma companies GSK and Roche, Dutch chip company ASML, Switzerland’s Nestlé and Novartis, Danish drugmaker Novo Nordisk, France’s L’Oréal and LVMH, the...
...Consider how Roche spent its cash. It acquired obesity drug developer Carmot Therapeutics for $2.7bn....
...Roche is conducting phase 1 clinical trials in humans on the candidate drug, which targets a bacterium known as carbapenem-resistant Acinetobacter baumannii, or CRAB....
...Read a transcript of this episode on FT.com...
...Caroline Sprod and Ali Bullock moved here from Hong Kong several years ago, choosing the countryside around Ponta Delgada on São Miguel island as the unlikely spot to establish their Gin Library in 2019...
...Just look at Roche (down 15.8 per cent in 2023, and a further 4.6 per cent year-to-date in 2024) and Nestlé (down 9 per cent and 5.1 per cent over the same periods)....
International Edition